Cargando…
Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation
BACKGROUND: Non muscle invasive bladder cancer (NMIBC) has the highest recurrence rate of any malignancy and as many as 70% of patients experience relapse. Aberrant DNA methylation is present in all bladder tumors and can be detected in urine specimens. Previous studies have identified DNA methylati...
Autores principales: | Reinert, Thomas, Borre, Michael, Christiansen, Anders, Hermann, Gregers G., Ørntoft, Torben F., Dyrskjøt, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463582/ https://www.ncbi.nlm.nih.gov/pubmed/23056278 http://dx.doi.org/10.1371/journal.pone.0046297 |
Ejemplares similares
-
Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies
por: Haldrup, Christa, et al.
Publicado: (2018) -
Targeted demethylation at ZNF154 promotor upregulates ZNF154 expression and inhibits the proliferation and migration of Esophageal Squamous Carcinoma cells
por: He, Wenting, et al.
Publicado: (2022) -
High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer
por: Laurberg, Jens Reumert, et al.
Publicado: (2014) -
Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma
por: Dyrskjøt, L, et al.
Publicado: (2012) -
Bioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder
por: Herbsleb, Malene, et al.
Publicado: (2008)